ArticleClinical practice and epidemiology in mental health : CP & EMH2007
Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network.
Article in Clinical practice and epidemiology in mental health : CP & EMH, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Psychoeducation (brief) for people with serious mental illness.The Cochrane database of systematic reviews · 2015Pooled it
- Psychoeducation for schizophrenia.The Cochrane database of systematic reviews · 2011Pooled it
- Prognostic impact of psychoeducation program completion on inpatients with schizophrenia: a pilot cohort study.BMC psychiatry · 2025Article
- Attitude towards mental help-seeking, motivation, and economic resources in connection with positive, negative, and general psychopathological symptoms of schizophrenia: a pilot study of a psychoeducation program.Frontiers in psychiatry · 2024Article
- Effects of a Psychoeducation Program for People with Schizophrenia Aimed at Increasing Subjective Well-Being and the Factors Influencing Those Effects: a Preliminary Study.The Psychiatric quarterly · 2020Article
- Productivity and deadweight losses due to relapses of schizophrenia in Japan.Neuropsychiatric disease and treatment · 2017Article
- Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia.Neuropsychiatric disease and treatment · 2013Article
- [Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].Der Nervenarzt · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe lack of compliance is associated with an increased risk of hospitalization and switching or augmentation of therapy when compared with being compliant. A synergy of drug therapy and psychosocial interventions can give more benefits in treatment.
methodsA perspective study was conducted on 150 patients with schizophrenia over 15 centers in Italy. The experimental group was treated with drug therapy, traditional psychosocial and psychoeducation for the patients and their families, while the control group received traditional psychosocial and drug intervention over 1 year.
resultsThe experimental group showed a significant statistical improvement (p < 0,05) in almost all the scales that have been assessed (BPRS, SAPS, SANS, SIMPSON-ANGUS SCALE, LANCASHIRE QL SCALE). Significant was the reduction of the number of hospitalizations and of days of hospital stay.
conclusionAs it is shown in international literature, psychoeducational intervention with schizophrenic patients and their families can reduce the occurrence of relapse.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.